Southwest Oncology Group 0408

dc.contributor.author	Abdalla, Eddie
dc.contributor.author	Eng, Cathy
dc.contributor.author	Madary, Alice
dc.contributor.author	Vauthey, Nicolas
dc.date.accessioned	2015-11-12T07:52:25Z
dc.date.available	2015-11-12T07:52:25Z
dc.date.issued	2015-11-12
dc.identifier.issn	1533-0028	en_US
dc.identifier.uri	http://hdl.handle.net/10725/2540
dc.language.iso	en	en_US
dc.title	Southwest Oncology Group 0408	en_US
dc.type	Article	en_US
dc.description.version	Published	en_US
dc.title.subtitle	Phase II Trial of Neoadjuvant Capecitabine/Oxaliplatin/Bevacizumab for Resectable Colorectal Metastases in the Liver	en_US
dc.author.school	SOM	en_US
dc.author.idnumber	201100945	en_US
dc.author.woa	N/A	en_US
dc.author.department	N/A	en_US
dc.description.embargo	N/A	en_US
dc.relation.journal	Clinical Colorectal Cancer	en_US
dc.journal.volume	5	en_US
dc.journal.issue	6	en_US
dc.article.pages	436-438	en_US
dc.keywords	5-Fluorouracil	en_US
dc.keywords	Leucovorin	en_US
dc.keywords	R0 resection	en_US
dc.identifier.doi	http://dx.doi.org/10.3816/CCC.2006.n.015	en_US
dc.identifier.ctation	Abdalla, E. K., Eng, C., Madary, A., & Vauthey, J. N. (2006). Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver. Clinical colorectal cancer, 5(6), 436-438.	en_US
dc.author.email	eddie.abdalla@lau.edu.lb